Health Canada
- Status: approved
Adalimumab plus different doses of oral glucocorticosteroid (Adalimumab plus different doses of oral glucocorticosteroid) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Peking Union Medical College Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.